Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.36 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.35 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | GRM5 | P41594 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3688482 | 0.77 | ALDH1A1 (0.40) | MAOAMAOB | |
| SCHEMBL6681357 | 0.76 | EPHX1 (0.43) | EPHX1ACHETAAR1HAO1SLC6A9 | |
| SCHEMBL5388844 | 0.76 | EPHX1 (0.45) | EPHX1ACHETAAR1HAO1SLC6A9 | |
| SCHEMBL2669681 | 0.75 | EPHX1 (0.47) | EPHX1ACHETAAR1HAO1MAOA | |
| SCHEMBL11518993 | 0.73 | HTT (0.54) | EPHX1SLC6A9 | |
| SCHEMBL7463775 | 0.72 | EPHX1 (0.45) | EPHX1ACHETAAR1HAO1SLC6A9 | |
| SCHEMBL776700 | 0.71 | ACHE (0.43) | EPHX1ACHETAAR1HAO1MAOA | |
| SCHEMBL14034696 | 0.69 | EPHX1 (0.40) | EPHX1ACHETAAR1HAO1SLC6A9 | |
| SCHEMBL776041 | 0.68 | ACHE (0.40) | EPHX1ACHETAAR1HAO1MAOA | |
| SCHEMBL9621779 | 0.68 | EPHX1 (0.42) | EPHX1TAAR1SLC6A9MAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1192165-A2 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES | Bristol-Myers Squibb Pharma Company (US) | 2002-04-03 | — | — | EP | disclosed |
| WO-2000077010-A2 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES | DU PONT PHARMACEUTICALS COMPANY (US) | 2000-12-21 | — | — | WO | disclosed |